Age, years (median, range) | 61 (26–81) |
Sex (Male:Female) | 63:19 |
Partial nephrectomy | Robotic 45 (54.9%), laparoscopic 16 (19.5%), open 21 (25.6%) |
Maximum diameter of the tumor (mm) | 30.4 ± 16.0 |
Pathological diagnosisa | Clear cell RCC 64 (78.0%), chromophobe RCC 2 (2.4%), papillary RCC 2 (2.4%), angiomyolipoma 7 (8.5%), oncocytoma 4 (4.9%), and others 3 (3.7%) |
In RCC (n = 68) | |
Pathological tumor stageb | pT1a 52 (76.5%), pT1b 14 (20.6%), pT2a 2 (2.9%) |
Tumor complexityc | Low 29 (42.6%), intermediate 29 (42.6%), high 10 (14.7%) |
Symptoms before TAE | Progressive anemia 24, severe hematuria 17, decrease in blood pressure 5, bleeding from drainage tube 5, severe pain 3 |